These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Influence of drugs on striatal and limbic homovanillic acid concentration in the rat brain. Westerink BH, Korf J. Eur J Pharmacol; 1975 Aug; 33(1):31-40. PubMed ID: 126169 [Abstract] [Full Text] [Related]
5. Inhibition of circling behavior by neuroleptic drugs in mice with unilateral 6-hydroxydopamine lesions of the striatum. Pycock C, Tarsy D, Marsden CD. Psychopharmacologia; 1975 Dec 31; 45(2):211-9. PubMed ID: 1240638 [Abstract] [Full Text] [Related]
8. 3-Methoxytyramine and different neuroleptics: dissociation from HVA and DOPAC. Groppetti A, Parenti M, Galli CL, Bugatti A, Cattabeni F, Di Giulio AM, Racagni G. Life Sci; 1978 Oct 30; 23(17-18):1763-8. PubMed ID: 31531 [No Abstract] [Full Text] [Related]
9. On the relevance of preferential increases of mesolimbic versus striatal dopamine turnover for the prediction of antipsychotic activity of psychotropic drugs. Waldmeier PC, Maître L. J Neurochem; 1976 Aug 30; 27(2):589-97. PubMed ID: 989496 [No Abstract] [Full Text] [Related]
10. Neuroleptic-induced hypersensitivity of striatal dopamine receptors in the rat as a model of tardive dyskinesias. Effects of clozapine, haloperidol, loxapine and chlorpromazine. Sayers AC, Bürki HR, Ruch W, Asper H. Psychopharmacologia; 1975 Aug 30; 41(2):97-104. PubMed ID: 1171492 [Abstract] [Full Text] [Related]
11. A rapid and simple behavioural screening method for simultaneous assessment of limbic and striatal blocking effects of neuroleptic drugs. Ljungberg T, Ungerstedt U. Pharmacol Biochem Behav; 1985 Sep 30; 23(3):479-85. PubMed ID: 2864704 [Abstract] [Full Text] [Related]
12. Effect of thioridazine, clozapine and other antipsychotics on the kinetic state of tyrosine hydroxylase and on the turnover rate of dopamine in striatum and nucleus accumbens. Zivkovic B, Guidotti A, Revuelta A, Costa E. J Pharmacol Exp Ther; 1975 Jul 30; 194(1):37-46. PubMed ID: 239221 [Abstract] [Full Text] [Related]
13. Effect of scopolamine on the efflux of dopamine and its metabolites after clozapine, haloperidol or thioridazine. Meltzer HY, Chai BL, Thompson PA, Yamamoto BK. J Pharmacol Exp Ther; 1994 Mar 30; 268(3):1452-61. PubMed ID: 8138957 [Abstract] [Full Text] [Related]
14. Enhancement of dopamine metabolism in rat brain frontal cortex: a common effect of chronically administered antipsychotic drugs. Mefford IN, Roth KA, Agren H, Barchas JD. Brain Res; 1988 Dec 20; 475(2):380-4. PubMed ID: 2905626 [Abstract] [Full Text] [Related]
15. Comparison of effects of drugs on dopamine metabolism in the substantia nigra and the corpus striatum of rat brain. Westerink BH, Korf J. Eur J Pharmacol; 1976 Nov 20; 40(1):131-6. PubMed ID: 991922 [Abstract] [Full Text] [Related]
16. Interaction of benzodiazepines with neuroleptics at central dopamine neurons. Keller HH, Schaffner R, Haefely W. Naunyn Schmiedebergs Arch Pharmacol; 1976 Jul 20; 294(1):1-7. PubMed ID: 12477 [Abstract] [Full Text] [Related]
17. Differential effects of certain dopaminergic drugs on the striatal concentration of dopamine metabolites, with special reference to 3-methoxytramine. Ponzio F, Achilli G, Perego C, Algeri S. Neurosci Lett; 1981 Nov 18; 27(1):61-7. PubMed ID: 7329624 [Abstract] [Full Text] [Related]
18. Preferential effect of noncataleptogenic neuroleptics on mesolimbic dopaminergic function. Bartholini G. Adv Biochem Psychopharmacol; 1977 Nov 18; 16():607-11. PubMed ID: 18902 [No Abstract] [Full Text] [Related]
19. Enhancement of haloperidol-induced increase in rat striatal or mesolimbic 3,4-dihydroxyphenylacetic acid and homovanillic acid by pretreatment with chronic methamphetamine. Toru M, Mataga N, Takashima M, Nishikawa T. Psychopharmacology (Berl); 1981 Nov 18; 74(4):316-20. PubMed ID: 6794073 [Abstract] [Full Text] [Related]
20. Effects of d-amphetamine on dopaminergic neurotransmission; a comparison between the substantia nigra and the striatum. Elverfors A, Nissbrandt H. Neuropharmacology; 1992 Jul 18; 31(7):661-70. PubMed ID: 1328918 [Abstract] [Full Text] [Related] Page: [Next] [New Search]